SHINE Enters Neutron Generator Technology Supply Agreement

SHINE Medical Technologies announced yesterday a long-term development and supply agreement with Phoenix Nuclear Labs to provide further funding for PNL to refine their neutron generator technology for the production of molybdenum-99. SHINE is one of several companies trying to get through the regulatory hurdles to begin the production of the medical isotope used in millions of medical procedures annually. The agreement calls for an exclusive supply of PNL’s neutron generators required for the the company’s planned isotope production facility in Janesville, Wis. “We’ve developed a strong partnership with PNL over the last several years, and they have demonstrated time and time again their ability to deliver key milestones on this important technology,” SHINE CEO Greg Piefer said in a statement. “They have a world class team that is way out in front of all other technologies for neutron generation at this scale. I have every confidence that they will be an excellent supplier, helping to support SHINE for many years into the future.”